Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Evolent Health Common Stock Secondary Offering
Davis Polk advised the underwriters in connection with a secondary offering of 7,500,000 shares of Class A common stock of…
Abbott Laboratories $2.9 Billion Exchange Offers and Consent Solicitations
Davis Polk advised the joint lead dealer managers in connection with the registered offers by Abbott Laboratories to…
Davis Polk Advises Penumbra, Inc. on Its Follow-On Offering
Davis Polk advised Penumbra, Inc. on its SEC-registered follow-on public offering of 1,495,000 shares of common stock for an…
Editas Medicine, Inc. $90 Million Follow-On Offering
Davis Polk advised the active joint book-running managers and representatives of the underwriters in connection with the $90…
Davis Polk Advises Valeant Pharmaceuticals International, Inc. on Its $6.25 Billion Refinancing
Davis Polk advised Valeant Pharmaceuticals International, Inc. in connection with a refinancing transaction pursuant to…
Bristol-Myers Squibb Company $1.5 Billion Notes Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters on an SEC-registered public…
Davis Polk Advises Auris Medical Holding AG on Its Offering of Common Shares and Warrants to Purchase Common Shares
Davis Polk advised Auris Medical Holding AG on its $10 million public offering of 10,000,000 of its common shares and 10,000…
Hermes Pardini R$763 Million Initial Public Offering
Davis Polk advised the joint bookrunners in connection with the initial public offering by Hermes Pardini and the selling…
Coherus BioSciences, Inc. Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the $125 million public offering of common stock of…
Davis Polk Advises McKesson Corporation on $1 Billion Notes Offering by Change Healthcare
Davis Polk advised McKesson Corporation in connection with the offering of $1 billion aggregate principal amount of notes…